GNH USA

Europe — EMA

Pantoprazole Ibe

GNH USA supplies Pantoprazole Ibe (Pantoprazole), a proton pump inhibitor for GERD, erosive esophagitis, Zollinger‑Ellison syndrome and NSAID‑induced ulcer

Pantoprazole

Request sourcing

1
Pack/s

What is Pantoprazole?

Pantoprazole, the active ingredient in Pantoprazole Ibe, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It is employed to reduce gastric acid secretion in conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent NSAID‑induced gastric ulcers.

GNH USA supplies Pantoprazole Ibe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Pantoprazole used for?

Pantoprazole Ibe acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal mucosa. - Erosive esophagitis: heals existing erosions and prevents further mucosal damage. - Zollinger‑Ellison syndrome: controls hypersecretion of gastric acid. - Prevention of NSAID‑induced gastric ulcers: lowers the risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

What are the side effects of Pantoprazole?

Pantoprazole Ibe may be associated with several adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased gas formation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal cramping. - Hypomagnesemia: low magnesium levels causing muscle weakness or arrhythmias. - Hepatic enzyme elevation: increased liver function test results. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder.

What precautions apply to Pantoprazole?

When using Pantoprazole Ibe, consider the following precautions. - Renal impairment: assess kidney function before initiation. - Hepatic impairment: use with caution in patients with liver disease. - Magnesium monitoring: check serum magnesium during prolonged therapy. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Drug interactions: review concomitant medications for potential interactions. - Store below 25°C: keep in original container, protect from moisture and light.

What does Pantoprazole interact with?

Pantoprazole Ibe can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Atazanavir, rilpivirine, and other antiretrovirals: reduced absorption and efficacy. - Ketoconazole, itraconazole, and other azole antifungals: markedly decreased bioavailability. - Clopidogrel: diminished activation leading to reduced antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in anticoagulant effect, monitor INR. - Digoxin: possible increase in serum levels, observe for toxicity. - Methotrexate: reduced clearance, watch for accumulation and adverse effects.

Frequently asked questions

What is Pantoprazole Ibe used for?+
Pantoprazole Ibe is an intravenous proton pump inhibitor used to reduce gastric acid secretion in patients with gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent gastric ulcers associated with non‑steroidal anti‑inflammatory drug use.
How does pantoprazole work?+
Pantoprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This blockade stops the final step of acid production, leading to a sustained increase in gastric pH and allowing ulcerated tissue to heal.
What is the usual dose of Pantoprazole Ibe?+
The dose of Pantoprazole Ibe is determined by the prescribing clinician based on the specific indication, severity of disease, and patient characteristics. The prescriber will select the appropriate infusion rate and duration according to clinical guidelines and individual patient needs.
Is Pantoprazole Ibe safe during pregnancy or breastfeeding?+
Safety data for Pantoprazole Ibe in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.
How do I order Pantoprazole Ibe from GNH USA?+
To order Pantoprazole Ibe, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Pantoprazole Ibe compare with other PPIs or alternative treatments?+
Pantoprazole Ibe offers rapid, controlled intravenous delivery, which can be advantageous in acute care settings where oral administration is not feasible. Compared with other PPIs, it has a similar efficacy profile but may have fewer drug‑interaction concerns with certain antiretrovirals and antifungals.
How should Pantoprazole Ibe be stored and handled?+
Pantoprazole Ibe should be stored below 25 °C, protected from moisture and light, and kept in its original packaging. Once reconstituted, it should be used promptly according to the manufacturer’s instructions and any unused solution discarded in accordance with local regulations.
How is Pantoprazole Ibe administered?+
Pantoprazole Ibe is administered by intravenous infusion. The healthcare professional will dilute the solution as directed and deliver it over the prescribed infusion time, typically via a peripheral or central line, ensuring aseptic technique throughout the process.
What are the most serious risks to watch for with Pantoprazole Ibe?+
Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, significant hypomagnesemia, hepatic enzyme elevations, and rare skin disorders like Stevens‑Johnson syndrome. Patients should be monitored for any signs of these conditions during treatment.
Who should not use Pantoprazole Ibe?+
Pantoprazole Ibe should be avoided in individuals with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is also advised for patients with severe hepatic impairment, those at risk of magnesium deficiency, and patients taking medications that may have major interactions without appropriate monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Pantoprazole
Route
Intravenous Use
Manufacturer
Ibe Pharma
Origin
EU

Related products

PANTOPRAZOLE SODIUM 20 mg/1

PANTOPRAZOLE SODIUM 20 mg/1

Pantoprazole · 20 mg

Pantoprazole Sodium
TABLET, DELAYED RELEASE
Camber Pharmaceuticals, Inc.
USA
PANTOPRAZOLE SODIUM 20 mg/1

PANTOPRAZOLE SODIUM 20 mg/1

Pantoprazole · 20 mg

Pantoprazole Sodium
TABLET, DELAYED RELEASE
Camber Pharmaceuticals, Inc.
USA
PANTOPRAZOLE SODIUM 20 mg/1

PANTOPRAZOLE SODIUM 20 mg/1

Pantoprazole · 20 mg

Pantoprazole Sodium
TABLET, DELAYED RELEASE
Camber Pharmaceuticals, Inc.
USA
PANTOPRAZOLE SODIUM 40 mg/1

PANTOPRAZOLE SODIUM 40 mg/1

Pantoprazole · 40 mg

Pantoprazole Sodium
TABLET, DELAYED RELEASE
Camber Pharmaceuticals, Inc.
USA